These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15781201)

  • 1. W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy.
    Newman B; Cescon D; Woo A; Rakowski H; Erikkson MJ; Sole M; Wigle ED; Siminovitch KA
    Mol Genet Metab; 2005 Apr; 84(4):374-5. PubMed ID: 15781201
    [No Abstract]   [Full Text] [Related]  

  • 2. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
    Watkins H
    Circulation; 2003 Mar; 107(10):1344-6. PubMed ID: 12642349
    [No Abstract]   [Full Text] [Related]  

  • 5. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy.
    Knöll R; Kostin S; Klede S; Savvatis K; Klinge L; Stehle I; Gunkel S; Kötter S; Babicz K; Sohns M; Miocic S; Didié M; Knöll G; Zimmermann WH; Thelen P; Bickeböller H; Maier LS; Schaper W; Schaper J; Kraft T; Tschöpe C; Linke WA; Chien KR
    Circ Res; 2010 Mar; 106(4):695-704. PubMed ID: 20044516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.
    Salazar-Mendiguchía J; Barriales-Villa R; Lopes LR; Ochoa JP; Rodríguez-Vilela A; Palomino-Doza J; Larrañaga-Moreira JM; Cicerchia M; Cárdenas-Reyes I; García-Giustiniani D; Brögger N; Fernández G; García S; Santiago L; Vélez P; Ortiz-Genga M; Elliott PM; Monserrat L
    Eur J Med Genet; 2020 Dec; 63(12):104079. PubMed ID: 33035702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
    Geier C; Gehmlich K; Ehler E; Hassfeld S; Perrot A; Hayess K; Cardim N; Wenzel K; Erdmann B; Krackhardt F; Posch MG; Osterziel KJ; Bublak A; Nägele H; Scheffold T; Dietz R; Chien KR; Spuler S; Fürst DO; Nürnberg P; Ozcelik C
    Hum Mol Genet; 2008 Sep; 17(18):2753-65. PubMed ID: 18505755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIM domain-wide comprehensive virtual mutagenesis provides structural rationale for cardiomyopathy mutations in CSRP3.
    Chauhan PK; Sowdhamini R
    Sci Rep; 2022 Mar; 12(1):3562. PubMed ID: 35241752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the genetic spectrum of hypertrophic cardiomyopathy: X marks the spot.
    Semsarian C; Ingles J
    Circ Cardiovasc Genet; 2013 Dec; 6(6):528-30. PubMed ID: 24347617
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene.
    Hartmannova H; Kubanek M; Sramko M; Piherova L; Noskova L; Hodanova K; Stranecky V; Pristoupilova A; Sovova J; Marek T; Maluskova J; Ridzon P; Kautzner J; Hulkova H; Kmoch S
    Circ Cardiovasc Genet; 2013 Dec; 6(6):543-51. PubMed ID: 24114807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
    D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
    J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Glu at codon 13 in the TCAP gene encoding the Z-disc protein titin-cap/telethonin is a rare non-synonymous polymorphism.
    Perrot A; Posch MG; Osterziel KJ
    Mol Genet Metab; 2006 Jun; 88(2):199-200. PubMed ID: 16490376
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a Novel Four and a Half LIM Domain 1 Mutation in a Chinese Male Presented with Hypertrophic Cardiomyopathy and Mild Skeletal Muscle Hypertrophy.
    Zhang BQ; Si N; Liu DF
    Chin Med J (Engl); 2015 Aug; 128(16):2269-70. PubMed ID: 26265627
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.
    Gallego-Delgado M; Gonzalez-Lopez E; Garcia-Guereta L; Ortega-Molina M; Gonzalez-Vioque E; Cobo-Marcos M; Alonso-Pulpon L; Garcia-Pavia P
    Int J Cardiol; 2015 Jul; 191():194-7. PubMed ID: 25965631
    [No Abstract]   [Full Text] [Related]  

  • 16. Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene.
    Binder JS; Weidemann F; Schoser B; Niemann M; Machann W; Beer M; Plank G; Schmidt A; Bisping E; Poparic I; Lafer I; Stojakovic T; Quasthoff S; Vincent JB; Rienmueller R; Speicher MR; Berghold A; Pieske B; Windpassinger C
    Circ Cardiovasc Genet; 2012 Oct; 5(5):490-502. PubMed ID: 22923418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
    Friedrich FW; Wilding BR; Reischmann S; Crocini C; Lang P; Charron P; Müller OJ; McGrath MJ; Vollert I; Hansen A; Linke WA; Hengstenberg C; Bonne G; Morner S; Wichter T; Madeira H; Arbustini E; Eschenhagen T; Mitchell CA; Isnard R; Carrier L
    Hum Mol Genet; 2012 Jul; 21(14):3237-54. PubMed ID: 22523091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy.
    Posch MG; Perrot A; Dietz R; Ozcelik C; Pankuweit S; Ruppert V; Richter A; Maisch B
    Mol Genet Metab; 2007 Jun; 91(2):207-8. PubMed ID: 17434779
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the human nebulette gene: a polymorphism in an actin-binding motif is associated with nonfamilial idiopathic dilated cardiomyopathy.
    Arimura T; Nakamura T; Hiroi S; Satoh M; Takahashi M; Ohbuchi N; Ueda K; Nouchi T; Yamaguchi N; Akai J; Matsumori A; Sasayama S; Kimura A
    Hum Genet; 2000 Nov; 107(5):440-51. PubMed ID: 11140941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gene-trap line reveals the dynamic patterns and essential roles of cysteine and glycine-rich protein 3 in zebrafish heart development and regeneration.
    Liang S; Zhou Y; Chang Y; Li J; Zhang M; Gao P; Li Q; Yu H; Kawakami K; Ma J; Zhang R
    Cell Mol Life Sci; 2024 Mar; 81(1):158. PubMed ID: 38556571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.